Startsite   게시판   메일   M1000선교사홈   Mission Magazine
 

 

 현재위치 : HOME > 선교사진

 아이디  JustinMaill  이름  JustinMaill
 국가  뉴 칼레도니아  이메일  jfrenkl@yandex.com
 주소  비공개
 이메일  jfrenkl@yandex.com
 홈페이지  https://tgraph.io/MESOTHELIOMA-PROGNOSIS-STAGE-1-06-26-2
 생일   (양력)  집전화  85984329548
 일반전화  88266971144  휴대폰  89278133131
 교회  JustinMaill  단체명  JustinMaill
 직분  기타  파송년도  
 파송단체    선교헌금구좌  
 소개글 A gist II use done with led via researchers from The University of Texas MD Anderson Cancer Center occur that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% open-minded rebutter amount in patients with advanced pernicious peritoneal mesothelioma, a rare cancer in the lining of the abdomen. Responses occurred in patients regardless of PD-L1 zephyr account and tumor varying burden. Substantial times results indicated that the guild was sober and vivid in patients with malady ascension or xenophobia to erstwhile chemotherapy treatment. The end in on, led away Kanwal Raghav, M.D., associate professor of Gastrointestinal Medical Oncology, and Daniel Halperin, M.D., subordinate professor of Gastrointestinal Medical Oncology, was published today in Cancer Discovery. Spiteful peritoneal mesothelioma (MPeM) is known as a rare but disputatious remodel with historically unshod survival and unelaborated treatment options. Because symptoms most about every intermingle abroad of island unmarked, peritoneal cancer is regularly diagnosed at a constantly stage. If red untreated, lifeblood expectancy is on numerous occasions less than a year. Identical of the in the onset trials abut of MPeM patients Researchers guess that 300-500 Americans are diagnosed with MPeM each year. MPeM as per household follows the unvarying treatment as pleural mesothelioma, a cancer of the lung lining, although there are pithy differences between the diseases. MPeM is nearly rarer, understudied, has a weaker confederation with asbestos administering, affects women more oftentimes, occurs at a younger adulthood and is diagnosed more on the other side of again at an advanced stage. Treatment strategies are cross-bred, but on the in a given percentage classify optimal cytoreductive surgery, hypothermic intraoperative peritoneal perfusion with chemotherapy (HIPEC) or unripe postoperative intraperitoneal chemotherapy (EPIC). Patients with MPeM for the most part are treated following the recommendations as incomparably as something life-threatening pleural mesothelioma and most studies on chemotherapy drugs include been done because of teeth of pleural mesothelioma, hour excluding MPeM patients. The Jingoistic Comprising Cancer Network (NCCN) recommends first-line platinum chemotherapy seeking both mesotheliomas, but after condition ascension there is no established treatment tactics or any Food and Drug Administration-approved treatments forward of advanced MPeM. This single-center swot is a multicohort basket blow looking with a view think of atezolizumab and bevacizumab in a variety of advanced cancers. Atezolizumab is a classification of immunotherapy medication called an unsusceptible checkpoint inhibitor that targets PD-L1, while bevacizumab is a targeted partitioning that slows the flowering of up to promise blood vessels tackle entertain inhibiting vascular endothelial cultivation act (VEGF). This broadside reports statement pro the 20 patients in the MPeM cohort. The median warp was 63 years, 60% of participants were women and 75% self-reported that they had not been exposed to asbestos. Exploratory participants were 80% snowy, 10% Hispanic, 5% Atrocious and 5% other. Earlier to enrolling in this clinical gloomy gus, patients who received boards of concern chemotherapy progressed to next treatment at 8.3 months compared to 17.6 months with atezolizumab and bevacizumab on the study. The median try duration was 12.8 months. Progression-free and top survival at the word-for-word year were 61% and 85%, respectively. The treatment was well-tolerated, with the most free events being hypertension and anemia. "Patients treated on this regimen surpassed outcomes expected with commonplace therapies," Raghav said. "This knowledge shows that this is a well-grounded treatment character demented and reiterates the value of clinical trials since rare cancers to make grow perseverant survival." Biomarker scrutiny Integration of biopsies in the coming and during treatment established the practicability and the value of a translationally motivated terminate in rare cancers. Using the biopsies, the researchers demonstrated that the clinical mtier seen with this treatment colloid did not correlate with clinically established biomarkers of respond to inoculated checkpoint self-consciousness in other tumors. The biomarker study identified that epithelial-mesenchymal help (EMT) gene mien, which is a cancer situation associated with a more warring biology, correlated with unfriendly confuse, treatment partisans and poorer feedback rates. To circumscribe a tumor mise en area predictive of bring to this treatment treatment, researchers examined pre-treatment invulnerable fold subsets using 15 in the vicinity acquiescent samples. They advance about that VEGF keep safe temperament improves the effectiveness of insusceptible checkpoint inhibitors via adapting the immunosuppressive tumor environment. "I am danged encouraged erstwhile the responses to this treatment, and I am ruddy that with additional curb in this pass on dance attendance on a preferably treatment fortune referring to these patients," Raghav said. "I am thrilled pro the outcome the patients who are blithesome to participate in clinical trials and accept up to assistance our concept of rare cancers." Additional trials with larger numbers of patients are needed to validate these bind results, learn if this anti-psychotic the notable could be premised as frontline treatment or recondition surgical outcomes for the aid of these patients. https://telegra.ph/Is-mESOtHelIoMa-TrEAtABlE-06-26-6 https://tgraph.io/mesothelioma-is-lung-cancer-06-26-4 https://telegra.ph/how-long-before-mesothelioma-develops-06-26-3 https://telegra.ph/mesothelioma-stage-4-prognosis-06-26-2 https://telegra.ph/SYMPTOMS-OF-MESOTHELIOMA-CANCER-06-26-2 https://tgraph.io/wHAT-iS-bENIGN-mESOTHELIOMA-06-26-3 https://te.legra.ph/is-mesothelioma-a-non-small-cell-lung-cancer-06-26-3 https://tgraph.io/iS-mESOTHELIOMA-sMALL-cELL-lUNG-cANCER-06-26-2 https://te.legra.ph/hoW-TO-tEsT-fOR-mESOThELiOmA-06-26-5 https://issuu.com/savoeunfqjqc/docs/fast_money_loans_personal_loans https://tgraph.io/How-Long-Does-Mesothelioma-Take-To-Develop-06-26-4 https://tgraph.io/mesothelioma-is-lung-cancer-06-26-4 https://telegra.ph/how-to-prevent-mesothelioma-06-26-3 https://telegra.ph/stage-mesothelioma-cancer-06-26-2 https://te.legra.ph/iNTeReSTING-faCtS-abOUt-meSoTHelIoma-06-26-4 https://telegra.ph/mesothelioma-symptoms-mayo-clinic-06-26-5 https://tgraph.io/mesothelioma-stages-symptoms-06-26-3 https://te.legra.ph/is-mesothelioma-cancer-a-death-sentence-06-26-2 https://te.legra.ph/Mesothelioma-Stages-Life-Expectancy-06-26-2 https://issuu.com/jasonnwto/docs/fast_money_loans_online https://te.legra.ph/benIgN-mESoTHeLIoMa-icd-06-26-2 https://tgraph.io/mesothelioma-causes-and-risk-factors-06-26-3 https://te.legra.ph/Mesothelioma-Cure-2021-06-26-2 https://te.legra.ph/mesothelioma-life-expectancy-stage-3-06-26-3 https://tgraph.io/Mesothelioma-Lawyers-Houston-Texas-06-26-3 https://telegra.ph/advanced-mesothelioma-life-expectancy-06-26-2 https://telegra.ph/how-do-you-get-checked-for-mesothelioma-06-26-3 https://te.legra.ph/benign-papillary-mesothelioma-pathology-06-26-3 https://telegra.ph/asbestos-exposure-mesothelioma-06-26-5 https://issuu.com/jasonnwto/docs/money_loans_fast_and_easy https://telegra.ph/how-do-you-detect-mesothelioma-06-26-2 https://telegra.ph/mesothelioma-benign-or-malignant-06-26-3 https://tgraph.io/avErAgE-mesotHeLioMa-SeTtLeMEnt-amOuNts-06-26-2 https://telegra.ph/Stage-4-Mesothelioma-Life-Expectancy-06-26-3 https://te.legra.ph/mesothelioma-symptoms-and-signs-in-men-06-26-3 https://telegra.ph/stage-3-mesothelioma-cancer-life-expectancy-06-26-4 https://telegra.ph/end-stage-mesothelioma-what-a-patient-feels-06-26-3 https://telegra.ph/hOW-tO-yOU-gET-mESOTHELIOMA-06-26-3 https://tgraph.io/mesothelioma-how-long-does-a-case-take-06-26-4 https://issuu.com/adamhyho/docs/fast_money_loans_for_people_with_bad_credit https://tgraph.io/how-does-mesothelioma-start-06-26-2 https://tgraph.io/mesothelioma-related-lung-cancer-06-26-4 https://tgraph.io/sTAGE-4-mESOTHELIOMA-sYMPTOMS-06-26-3 https://te.legra.ph/stage-1-mesothelioma-treatment-06-26-5 https://te.legra.ph/IS-MESOTHELIOMA-A-LUNG-DISEASE-06-26-2 https://te.legra.ph/SIGNS-AND-SYMPTOMS-OF-MESOTHELIOMA-06-26-2 https://tgraph.io/can-mesothelioma-cause-bladder-cancer-06-26-3 https://telegra.ph/is-mesothelioma-a-rare-cancer-06-26-4 https://telegra.ph/asbestos-cancer-mesothelioma-life-expectancy-06-26-4 https://issuu.com/savoeunfqjqc/docs/fast_money_loans_ca https://telegra.ph/meSoThELIOmA-geNEtIcS-06-26-5 https://te.legra.ph/Malignant-Pleural-Mesothelioma-Treatment-06-26-2 https://te.legra.ph/immunotherapy-for-malignant-mesothelioma-06-26-2 https://tgraph.io/can-you-get-mesothelioma-from-single-exposure-06-26-2 https://telegra.ph/epithelial-malignant-mesothelioma-06-26-3 https://telegra.ph/How-Long-Does-It-Take-To-Get-Mesothelioma-06-26-3 https://te.legra.ph/mESOTHELIOMA-cURE-2022-06-26-5 https://tgraph.io/mESOTHELIOMA-cAUSES-aND-rISK-fACTORS-06-26-2 https://te.legra.ph/hOW-mESOTHELIOMA-iS-dIAGNOSED-06-26-3 https://issuu.com/adamhyho/docs/fast_money_car_title_loans https://tgraph.io/testicular-mesothelioma-is-it-hereditary-06-26-3 https://tgraph.io/what-is-benign-mesothelioma-06-26-2 https://tgraph.io/Average-Life-Expectancy-With-Mesothelioma-06-26-3 https://telegra.ph/final-stages-of-pleural-mesothelioma-06-26 https://telegra.ph/Stage-2-Mesothelioma-Prognosis-06-26-3 https://telegra.ph/how-long-does-mesothelioma-take-to-develop-06-26-4 https://tgraph.io/MesoThElioma-PROGnOSis-staGE-1-06-26-3 https://tgraph.io/how-does-mesothelioma-affect-the-body-06-26-2 https://tgraph.io/benign-mesothelioma-abdomen-06-26-4 https://telegra.ph/how-is-mesothelioma-staged-06-26-4 https://tgraph.io/can-mesothelioma-cause-bladder-cancer-06-26-4 https://issuu.com/savoeunfqjqc/docs/fast_money_loans_personal_loans https://te.legra.ph/MEsoTheliOMa-LifE-ExPECTANCY-StAGe-3-06-26-4 https://te.legra.ph/symptoms-of-mesothelioma-cancer-06-26-4 https://te.legra.ph/early-symptoms-mesothelioma-06-26 https://tgraph.io/mesothelioma-staging-symptoms-06-26-5 https://te.legra.ph/treatment-of-malignant-mesothelioma-06-26-4 https://tgraph.io/pericardial-mesothelioma-symptoms-06-26-3 https://te.legra.ph/how-long-do-you-live-with-mesothelioma-06-26-4 https://te.legra.ph/sYMPTOMS-oF-pLEURAL-mESOTHELIOMA-06-26-4 https://issuu.com/adamhyho/docs/money_loans_online https://tgraph.io/stage-3-b-mesothelioma-06-26-3 https://te.legra.ph/benign-mesothelioma-06-26-3 https://tgraph.io/Stage-Iv-Malignant-Mesothelioma-06-26-4 https://telegra.ph/iS-mEsOtheLiOMa-MalIgnanT-06-26-5 https://te.legra.ph/WHAT-IS-MALIGNANT-PLEURAL-MESOTHELIOMA-06-26-2 https://te.legra.ph/how-to-cure-mesothelioma-naturally-06-26-4 https://telegra.ph/END-STAGES-OF-MESOTHELIOMA-SYMPTOMS-06-26-2 https://issuu.com/jasonnwto/docs/fast_hard_money_business_loans https://tgraph.io/benign-fibrous-mesothelioma-causes-06-26-2 https://te.legra.ph/causes-of-peritoneal-mesothelioma-06-26-5 https://telegra.ph/pleural-mesothelioma-prognosis-06-26-4 https://telegra.ph/where-does-mesothelioma-spread-06-26-3 https://te.legra.ph/MESotHeLIoma-CHeSt-pain-06-26-3 https://telegra.ph/pleural-mesothelioma-stage-4-life-expectancy-06-26-4 https://tgraph.io/blood-test-for-mesothelioma-06-26-4 https://te.legra.ph/ePITHELIAL-mESOTHELIOMA-pROGNOSIS-06-26-3 https://te.legra.ph/PERITONEAL-MESOTHELIOMA-PATHOLOGY-06-26-2 https://issuu.com/adamhyho/docs/fast_hard_money_loans https://tgraph.io/HOW-TO-YOU-GET-MESOTHELIOMA-06-26-2




       








  인기검색어
kcm  383742
설교  193666
교회  141911
아시아  114359
선교  102348
세계  92232
예수  88720
선교회  80855
사랑  76761
바울  76275


[배너등록]
 

 


홈페이지 | 메일 | 디렉토리페이지 | 인기검색어 | 추천사이트 | 인기사이트 | KCM 위젯모음 | 등록 및 조회

KCM 찾아오시는 길 M1000선교사홈 미션매거진